WuXi Biologics Earns CDMO Leadership Awards for the Ninth Straight Year WuXi Biologics has once again reinforced its leadership position in the global biologics outsourcing sector, announcing that it has…
Kerendia™ Receives EU Approval for Expanded Use in Adults with Heart Failure and LVEF ≥40% Bayer has achieved a major regulatory milestone with the approval of Kerendia (finerenone) by the…
FDA Approves Higher-Dose SPINRAZA® (Nusinersen) Regimen for Spinal Muscular Atrophy Biogen Inc. has announced a significant regulatory milestone with the approval of a new high-dose regimen of SPINRAZA (nusinersen) by…
CVS Pharmacy® Marks Opening of Its First Pharmacy-Only Location in Chicago CVS Health has announced a significant expansion of its retail pharmacy strategy with the launch of a new “pharmacy-only”…
Insulet Appoints Mike Panos as Chief Commercial Officer to Drive Global Growth of Omnipod Platform Insulet Corporation, a global leader in tubeless insulin pump technology, has announced the appointment of…
CorVista Health Unveils Machine Learning–Driven Noninvasive Approach to Detect Cardiac Ischemia at ACC.26 CorVista Health has announced promising new clinical data supporting a novel, noninvasive diagnostic approach for detecting cardiac…
Merck Presents Phase 3 CORALreef AddOn Data for Enlicitide, Highlighting Strong LDL-C Reductions and Potential as First Oral PCSK9 Inhibitor Merck has unveiled compelling late-breaking results from its Phase 3…
LEO Pharma Showcases New Real-World Data on Tralokinumab at AAD 2026, Highlighting Benefits Across Diverse Atopic Dermatitis Populations LEO Pharma has presented new post-hoc analyses from its ongoing TRACE study,…
Alnylam Highlights New Cardiovascular Data at ACC.26, Reinforcing Potential of RNAi Therapies in ATTR-CM and Hypertension Alnylam Pharmaceuticals has unveiled a comprehensive set of new clinical and real-world findings from…
Meiji Seika Pharma Invests in Centivax to Advance Universal Vaccine Innovation and Broaden Global Infectious Disease Preparedness Meiji Seika Pharma Co., Ltd., a leading Japanese pharmaceutical company with a long-standing…
Biocytogen Enters Platform Licensing Agreement with Taisho to Expand Use of RenNano® Antibody Discovery Technology Biocytogen Pharmaceuticals (Beijing) Co., Ltd., a global biotechnology company recognized for its innovation in antibody-based…
PepGen Reports Encouraging Phase 2 Data for PGN-EDODM1 in Myotonic Dystrophy Type 1, Advances Higher-Dose Cohort in FREEDOM2 Trial PepGen Inc., a clinical-stage biotechnology company focused on advancing next-generation oligonucleotide…